S
olid organ transplant places tremendous demands on patients in terms of follow-up and adherence. Patients of low socioeconomic status (SES) may experience barriers to consistent follow-up and adherence, including low health literacy, social support, and financial resources. Such barriers could lead to poorer post-transplant outcomes. Despite the plausibility of such an effect, evidence is conflicting. Although most published studies report an association between SES and solid organ transplant outcomes, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] others find no independent association. [21] [22] [23] [24] [25] [26] [27] Evidence is particularly limited in heart transplant (HT); whereas racial disparities are well-documented, [28] [29] [30] [31] [32] [33] only 3 studies to date report an association between SES and post-HT outcomes. 1, 2, 34 Why low-SES patients might experience worse outcomes after HT remains unclear. Racial disparities in graft quality, donor-recipient matching, and quality of care have been documented 29 ; these factors may also drive SES disparities in HT outcomes. Low health literacy may pose a barrier to treatment adherence. Limited financial resources among low-SES patients may also adversely affect adherence and access to care. Expansion of public insurance has aimed to mitigate this disadvantage, but whether HT outcome disparities have decreased as a result is unknown.
In addition, which particular aspects of SES are most important in driving HT outcomes remains unclear. Explanations of SES disparities often focus on individuallevel factors including patient's education, income, and insurance status; however, characteristics of a patient's living environment may also be important. In support of this, low neighborhood SES (nSES) is associated with coronary heart disease incidence 35 and outcomes in heart failure 36 even after adjustment for individual SES. In contrast, there was no such association with nSES in a cohort of liver transplant patients. 8 Whether both nSES and individual SES are independent predictors of HT outcomes remains unknown, as no prior studies have included both in multivariate analyses.
To address these gaps, we aimed to characterize the stand-alone associations of both patient-level SES and nSES with graft quality and post-HT outcomes using the United Network for Organ Sharing (UNOS) database. Moreover, we investigated whether any observed SES associations vary over time. Finally, we assessed whether differences in baseline clinical risk factors and graft characteristics account for any observed SES disparities in outcomes. These analyses could help elucidate specific risk factors and mechanisms responsible for socioeconomic disparities in transplant outcomes and inform future efforts to resolve these disparities.
METHODS
We used the UNOS database, which includes a comprehensive registry of all heart transplants performed in the United States. Our primary sample included the adult (≥18) subset who underwent orthotopic HT between April 1, 1994, and April 1, 2014, excluding multi-organ transplants and patients with prior HT. There were no other exclusion criteria. Although the UNOS database also includes patients transplanted before April 1994, these were excluded from the primary analysis because of the absence of data on several relevant covariates. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Using data on race and ethnicity in the UNOS database, we grouped patients into 4 categories: black, Hispanic, white (excluding those identified as Hispanic), and Asian or other, which included patients of mixed, unknown, or other race. Whites were used as the reference group in multivariate analyses. To characterize individual-level SES, we used 2 routinely collected measures from the UNOS database: (1) educational attainment and (2) insurance status. Education was categorized as less than high school, high school only, or any postsecondary (college) education, with less than high school as the reference group. Insurance status was categorized as Medicare, Medicaid, or private or other (usually private insurance), with private or other as the reference group.
To characterize nSES, we employed the Agency for Healthcare Research and Quality SES index which is previously described. 34 Briefly, this index is constructed on the basis of 7 socioeconomic factors obtained from the 2005 to 2009 compilation of the American Community Survey, related to
WHAT IS NEW?
• Black and low socioeconomic status (SES) patients have higher rates of death and retransplant after heart transplant.
• Low-SES patients also have poorer adherence to immunosuppressive medications and higher rates of hospitalization, rejection, and infection. Low-SES patients differ in baseline clinical characteristics and blacks are significantly less likely to receive race-and HLA-matched grafts, but these differences do not account for disparities in outcomes.
• Disparities by SES may have diminished over the last two decades, but the black-white disparity in outcomes has not changed.
WHAT ARE THE CLINICAL IMPLICATIONS?
• Low-SES and black patients experience poorer outcomes after heart transplant. Poorer adherence likely contributes to these disparities.
• Efforts should be taken to identify and counsel low SES and other patients at risk of nonadherence, which may stem from low health literacy, limited social support, and financial burden.
• Further studies are needed to pinpoint the causes of SES disparities in heart transplant outcomes, which may be amenable to intervention.
income, housing value, crowding, educational attainment, poverty rate, and unemployment. This nSES score was calculated for every zip code represented by patients in our sample, with zip codes serving as a proxy for neighborhoods. Patients were grouped into quartiles and deciles of nSES based on this calculated score for their zip code of residence.
Covariates included demographics (age, sex, and race) and clinically relevant baseline risk factors, as identified based on clinical plausibility and literature review. These included functional status (classified as no, some, or full assistance required with daily activities), utilization of any life support (including treatment with extracorporeal membrane oxygenation, mechanical ventilation, prostaglandins, intra-aortic balloon pump, ventricular assist device, and inhaled nitric oxide), intensive care unit admission, renal dysfunction (defined as creatinine ≥2.5), and liver dysfunction (defined as total bilirubin ≥2.0)-all determined at the time point immediately before transplant. Also included were baseline comorbidities (diabetes mellitus, obesity [body mass index ≥30], history of stroke), history of an implantable cardiac defibrillator, cause of heart failure (ischemic versus nonischemic), and whether the patient was assigned the highest priority UNOS status at the time of listing. Donor and graft characteristics considered for inclusion in multivariate analyses included donor age, graft ischemic time (expressed as logarithm), and sex-and race-matching between donor and recipient; of note, each of these variables has been shown to independently predict post-HT mortality in previously published multivariate models. 37 Other donor characteristics considered for inclusion were hypertension, diabetes mellitus, clinical infection, history of smoking, history of cancer, illicit drug use in last 6 months, and terminal creatinine and BUN-to-creatinine ratio. Additional candidate variables related to donor-recipient compatibility included human leukocyte antigen (HLA) mismatch, cytomegalovirus (CMV) mismatch, and weight mismatch. HLA mismatch was defined as having ≥4 mismatched antigens. CMV mismatch was defined as the presence of a CMV-positive (by IgG serology) donor and a CMV-negative recipient. Weight mismatch was defined as a ratio of donor to recipient weight <0.8.
The primary outcome was time until death or retransplant. Secondary outcomes included time to hospitalization for any cause, hospitalization for rejection, hospitalization for infection, an event of noncompliance with immunosuppressive medications (ISMs) deemed to be clinically significant, and an ischemic event, defined as either stroke or an event related to coronary artery disease deemed to be clinically significant. The study was approved by the Institutional Review Board of Columbia University Medical Center.
Statistical Analysis
Baseline characteristics were compared across nSES quartiles using the Pearson χ 2 test for categorical variables and Kruskal-Wallis test for continuous variables. The prevalence of SES characteristics was calculated by year of transplant. Bivariate linear regression, with year as the single predictor variable, was used to assess for the presence of any significant time trend in each SES characteristic. Kaplan-Meier analyses were used to compare unadjusted risks of each outcome by SES strata for each covariate of interest (ie, nSES, insurance, race, and education). In multivariate analyses, Cox proportional hazards regression models included the above clinical covariates, selected donor and graft characteristics, year of transplant, and all SES variables together to evaluate their adjusted associations with the primary outcome. In these multivariate models, nSES was included by decile (and not by quartile as above) to more precisely characterize its association with the primary outcome.
Donor and graft characteristics were selected for inclusion in these multivariate analyses as follows: first, it was decided a priori that donor age and graft ischemic time would be included in multivariate analyses, given a clinically plausible effect on graft quality and outcomes. In addition, HLA mismatch was chosen for inclusion a priori, as associations between race and HLA-matching and between HLAmatching and post-HT outcomes have been consistently demonstrated. 33 Thus, there was a high suspicion that HLA mismatch would be an important mediator of racial and socioeconomic disparities in the primary outcome. Next, candidate donor and graft characteristics showing no significant association (P>0.05) with the primary outcome in univariate Cox proportional hazards regression were excluded. The remaining candidate variables, along with donor age, graft ischemic time, and HLA mismatch, were combined in a multivariate Cox proportional regression model. Only those candidate variables which retained significant associations (P≤0.05) with the primary outcome in this model were included in further analyses.
Patients with missing values for nSES were excluded from the analysis, as were patients with >2 missing values for other covariates. Where relevant data were missing, patients were assumed to be matched to the donor based on race, sex, and HLA type. Missing values for other binary variables were replaced with no; that is, the absence of a given condition was assumed. Missing values for education, insurance, race, and functional status were replaced with high school only, private or other, white, and some assistance required, respectively. Where data on a continuous variable were missing, the mean across the included sample was assigned.
Covariate domains were added to the model in a stepwise fashion to determine which domains mediate the associations of race and nSES with outcomes. The first set of adjusted models included race, SES characteristics, sex, age at transplant, and calendar year of transplant. In the next set of adjusted models, baseline clinical characteristics (as listed in Table 1) were added. In the final set of adjusted models, donor and graft characteristics-selected using the procedure described above-were added. A sensitivity analysis was performed in which all candidate graft and donor characteristics-regardless of their associations with the primary outcome-were included in the final adjusted models.
To assess whether race and SES associations with the primary outcome vary over time, 2 analyses were used. In the first analysis, we fit multivariate models which included multiplicative interaction terms between year of transplant and (1) nSES score, as a continuous variable, (2) black, (3) Hispanic, and (4) Asian or other race. In the second analysis, we fit multivariate models separately for subjects transplanted in each of 2 time periods (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) to compare associations over time. This time designation, with 2 periods of unequal duration, was chosen deliberately such that the number of death or retransplant events were approximately equal between the 2 cohorts. For ease of interpretation and to allow for a nonlinear interaction between SES and time, we used nSES quartile (and not the continuous score) in this second analysis. In both of these analyses examining time trends, we excluded insurance and education variables from the multivariate models. The rationale for their exclusion is that these markers likely convey changing degrees of SES disadvantage over the time span of observation. In particular, expanding public insurance coverage has significantly altered the SES profile of those on Medicaid and Medicare, and increasing access to higher education has changed the profile of those with a college degree. As the degree of disadvantage conveyed by these markers has changed over time, any time trends in their associations with outcomes would be difficult to interpret. In the absence of education and insurance variables, nSES was felt to be an adequate proxy for overall SES.
RESULTS
The preliminary study population included 36 736 patients. Among these, 1299 (3.5%) were excluded from multivariate analyses because of the absence of their zip code of residence in the UNOS data set. Other covariates with rates of missing values >1% included education, insurance status, stroke, diabetes mellitus, renal dysfunction, liver dysfunction, prior implantable cardiac defibrillator, and functional status (Table 1 ). An additional 1544 (4.2%) patients were excluded because of absence of >2 covariates. Excluded patients were from earlier years and had higher nSES scores, lower rates of college education, and higher rates of white race and private or other insurance. They also differed in terms of some clinical characteristics, as shown in Table I Patients in lower nSES quartiles were slightly younger, less educated, and more likely to be female, black, Hispanic, on Medicaid, and on Medicare (Table 1) . Patients in higher nSES quartiles were more frequently white, of Asian/other race, and privately insured. Baseline clinical characteristics were similar across all quartiles, though higher nSES was associated with lower rates of diabetes mellitus and obesity and higher rates of prior implantable cardiac defibrillator and ischemic cardiomyopathy. Low nSES was associated with lower donor age and ischemic time, lower rates of race-and HLA-matching, and higher rates of donor smoking history and CMV-matching. When compared with whites, blacks had lower rates of race-, sex-, and HLA-matching, higher rates of CMVmatching, lower rates of donor smoking history, and no difference in donor age or ischemic time ( Table 2) .
During the time span of observation (1994-2014), 40% of the study sample experienced the primary composite outcome of death or retransplant. In unadjusted analyses (Figure 1 ), there was a higher risk of the composite outcome associated with the lowest (HR, and third-lowest nSES quartiles, respectively; P<0.0001 for all comparisons. In multivariate models adjusting for all race and SES variables, the associations with college education, black race, Medicare, and Medicaid with the composite outcome were slightly attenuated but remained statistically significant (Figure 2A) . Patients in the lowest 4 deciles of nSES had a significantly higher risk of the composite outcome, in comparison to the highest decile. Further adjusting for clinical characteristics did not appreciably change any of these observed associations ( Figure 2B ). The addition of graft characteristics in fully-adjusted models attenuated the association with black race, but only slightly (HR before adjustment, 1.27; 95% CI, 1. posite outcome. In a sensitivity analysis, adjustment for a more exhaustive set of donor and graft characteristics did not change these observed associations (Table  III in the Data Supplement) .
There were significant increases over time in the proportion of transplant recipients who are black, Hispanic, Asian or other race ( Figure 3A ; P<0.0001), college educated ( Figure 3B ; P<0.0001), on Medicare ( Figure 3C ; P<0.0001), and on Medicaid (P=0.032). When separate multivariate models were fit for earlier (1994) (1995) (1996) (1997) (1998) (1999) (2000) and later (2001-2014) transplant recipients, the risk associated with black race was virtually unchanged (Figure 4) . The association of lowest nSES quartile with the primary outcome decreased in magnitude but was significant in both time periods. Second and third nSES quartile were associated with an increased risk of the primary outcome only in the earlier cohort (q2: HR, 1.12; 95% CI, 1.06-1.19; P=0.0009; q3: HR, 1.08; 95% CI, 1.01-1.14; P=0.038), with no associations present in the later cohort (q2: HR, 1.01; 95% CI, 0.94-1.08; P=0.76; q3: HR, 0.98; 95% CI, 0.91-1.05; P=0.65).
Tests of interaction between time period and SES variable showed that the risks associated with second and third nSES quartile decreased significantly over time (P<0.05); however, the reduction over time in the risk associated with lowest nSES quartile was not significant. In multivariate models, the multiplicative interaction term between year of transplant and continuous nSES score was positive, implying a diminishing association over time between nSES and the primary outcome (ie, trending to the null). However, this interaction term was not statistically significant.
DISCUSSION
Our study confirms that there are significant socioeconomic and racial disparities with respect to HT outcomes in the United States. We find college-educated transplant recipients have 18% reduced rates of death or retransplant, whereas being black, on Medicaid, on Medicare, and residing in a low nSES each confer 22% to 33% increased risk. Low nSES also confers higher risk of other adverse post-HT outcomes including hospitalization, rejection, infection, ischemic event, and noncompliance. Whereas prior studies performed in smaller, narrow cohorts have not consistently found such associations, our study-performed in a large, comprehensive panel of US HT recipients over 2 decades-offers definitive evidence of an SES disparity in the general population.
One theory for this disparity is that patients of low-SES represent a higher-risk clinical substrate at the time of transplant, which could account for their poorer outcomes. Another hypothesis is that low-SES patients receive poorer-quality or more poorly-matched grafts, leading to poorer outcomes. However, we find little support for either theory. We find no difference by SES in most relevant clinical risk factors and note that lower nSES is associated lower donor age and shorter graft ischemic time, both suggestive of higher graft quality. Moreover, the associations of SES variables with graft failure persist after full adjustment for baseline clinical risk factors and graft characteristics. Together these findings indicate that SES exerts a direct, disease-modifying effect on patient outcomes after HT.
Confirming prior findings, 29 we report that blacks are more likely to receive HLA-mismatched and race- mismatched grafts, but this only accounts for a small portion of the racial disparity in outcomes. Moreover, the racial disparity persists after adjusting for a wide array of socioeconomic factors and comorbidities. This supports the hypothesis that intrinsic biological factors are driving poorer outcomes among blacks. In particular, higher rates of rejection among blacks may be driven by increased sensitization and peak panel of reactive antibodies. 38 Testing this hypothesis would require more complete data than what is available in the UNOS database; thus an exploration of the role of panel reactive antibodies and other biological mediators is outside the scope of our study.
Another novel finding of our study is that both individual-level SES and nSES variables are independently associated with post-HT outcomes. In contrast, a similarly designed study of 29 481 liver transplant patients showed that individual education and public insurance status, but not nSES, had independent associations with post-transplant outcomes. We note that Medicaid status confers the highest adjusted risk (HR, 1.29) of the primary outcome, suggesting that the effect of individual SES is more prominent. However, the standalone association of nSES suggests that there is something inherent to an individual's place of residence that significantly impacts outcomes. Notably, the adjusted risk associated with living in the poorest decile of neighborhoods (HR, 1.19) is roughly double the risk of deciles 2 through 4 (HR, 1.08-1.11). This suggests that the effect of SES on outcomes is not linear, but becomes pronounced only above some threshold of severe socioeconomic disadvantage.
That living in the poorest neighborhoods (HR, 1.19) is nearly as influential as black race (HR, 1.25), a firmlyestablished risk factor with likely biological and social underpinnings, adds to growing evidence of the importance of place in shaping health. The reasons for this place effect remain unclear. 39 It may stem from aspects of the physical or social environment or from differences in local quality of care, as black patients (and likely low-SES patients in general) more often undergo HT at worse performing centers. 29 Our data set lacked reliable indicators of quality of care; further studies are needed to investigate whether differences in quality of care contribute to SES disparities in post-HT outcomes.
There are several other plausible explanations for socioeconomic disparities in transplant outcomes. Poorer adherence to ISMs, monitoring of ISM levels, and rejection surveillance likely plays a role. Consistent with this, we find that low nSES is associated with a 76% increased risk of noncompliance with ISMs andlikely as a result-a 28% increased risk of rejection. This disparity may stem from poor health literacy and erroneous beliefs about ISMs, which have been shown to predict poor adherence. 40 Financial burden likely also plays a role, as 31% of transplant recipients report that ISM expenses have had an impact on their lives. This reported financial strain is more prevalent among patients of low SES. 41 We present evidence that SES disparities in HT outcomes may be decreasing over time. Previously (1994 Previously ( -2000 , the middle class of patients (nSES quartiles 2 and 3) experienced significantly higher risks of the composite outcome than the highest SES group. This association has significantly decreased over time and is absent in a more recent cohort (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . In contrast, the risk associated with the lowest SES group (nSES quartile 1) did not significantly decrease between these 2 time periods. Moreover, a test of interaction between nSES score and year of transplant-when both were modeled as continuous variables-showed a nonsignificant decrease in the SES effect.
The use of an interaction term between continuous nSES score and year of transplant assumes that both (1) the effect of SES and (2) its change over time are linear. That this interaction term is nonsignificant likely reflects the fact that neither of these assumptions is valid. As noted above and depicted in Figure 2 , the effect of SES on outcomes appears nonlinear. Moreover, Figure 4 suggests that the associations with second and third nSES quartile trend to the null during the early time period (1994) (1995) (1996) (1997) (1998) (1999) (2000) , with a plateau thereaftersuggesting a nonlinear, J-shaped relationship between the SES effect and time. Thus, we contend that a continuous interaction term poorly models reality and place more stock in the findings in Figure 4 , which indicates that disparities are narrowing for some, but not for the lowest SES patients.
If disparities are narrowing, the cause is likely multifactorial. Improvements over time in the scope and stability of public insurance coverage may alleviate financial strain and resulting nonadherence among low-SES patients. Transplant programs invest heavily in patient counseling and education, which may increasingly offset the disadvantages of low baseline health literacy. These mechanisms combined with the broader health system and policy changes have likely helped reduce SES disparities in HT outcomes. In contrast, we find that the disadvantage associated with black race has not improved over time. Further studies are needed to identify the underlying drivers of this persistent race disparity, which as we show in this study, are not explained by differences in baseline clinical risk factors or in graft compatibility. Our study has multiple limitations. Missing data required exclusion of 8% of patients from our multivariate analyses. Excluded patients had, on average, an earlier year of transplant and differ from the remainder of the sample in ways that reflect this, including lower rates of black race, college education, and public insurance. However, it is unlikely that they differed from included patients in a way that would bias our primary findings. Our ascertainment of SES is also limited. To proxy for neighborhood we use zip codes, which are sometimes large and heterogeneous. An averaged statistic across a zip code may not accurately represent an individual's immediate environment. 42 Thus, use of zip code as a proxy could bias estimates of the neighborhood effect toward the null, while inflating the observed effect of race and other SES variables (which would capture incompletely measured effects of neighborhood). As in prior studies, we were constrained by absence of more specific area information (eg, census tract, block group) in the UNOS registry.
We faced additional limitations related to data availability. Donor age and ischemic time were our sole variables related to graft quality, as we lacked echocardiographic data and biomarkers used to assess graft quality. Thus, it remains possible that there are unmeasured differences in graft quality by SES that contribute to disparities in outcomes. There is also imprecision in the ascertainment of outcomes. Although our primary outcome of death or retransplant is objective and likely reliably measured, secondary outcomes such as nonadherence or CAD events deemed to be clinically significant are not imprecisely defined and open to subjective interpretation.
In conclusion, there are significant socioeconomic disparities with respect to HT outcomes in the United States, which have diminished somewhat over time. These disparities are not accounted for by differences in graft characteristics, donor-recipient matching, or clinical risk factors at baseline. Both individual-and neighborhood-level components of SES are independently associated with outcomes. Further studies are needed to identify the mechanisms underlying these associations; this may help inform strategies to mitigate the persistent disparity in transplant outcomes.
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